Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about AKTX, unsubscribe in one click. Privacy
AKTX reported $7.7M in cash and short-term investments (as of Jun 30, 2026) and used about $2.8M/quarter in operations, an estimated runway of 8.2 months at that rate (BioRadar estimate, not company guidance).
Dilution pressure: 75 · High
These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least a one-year period following the issuance of these condensed consolidated financial statements.10-Q, Aug 2026
Recent financing filings on SEC EDGAR:
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when AKTX files for a raise →
| Holder | Type | Shares | % of shares | As of |
|---|---|---|---|---|
| Hoyoung Huh, M.D., Ph.D. | 5%+ holder (13G) | 18,199,697,667 | 11.68% | 2026-03-02 |
| Samir R. Patel | 5%+ holder (13D) | 9,725,215,000 | 6.24% | 2026-03-02 |
| Ray Prudo, M.D. | 5%+ holder (13D) | 8,391,326,467 | 5.39% | 2026-03-02 |
| Bank of Montreal | Institution (13G, 5%+) | 8,000,000,000 | 5.14% | 2026-06-30 |
| MMCAP International Inc. SPC | 5%+ holder (13G) | 8,000,000,000 | 5.14% | 2026-06-02 |
| White Lion Capital LLC | 5%+ holder (13G) | 7,001,638,477 | 4.50% | 2026-08-07 |
| Hoyoung Huh Director, 10% owner · +7.92M options |
Insider | 4,805,311 | 0.00% | 2025-03-20 |
| Raymond Prudo-Chlebosz Director · +2.06M options |
Insider | 2,904,728 | 0.00% | 2025-03-20 |
| Sandip I Patel Director · +826,432 options |
Insider | 556,749 | 0.00% | 2025-04-25 |
| Samir Rashmikant Patel Director, 10% owner · +1.71M options |
Insider | 101,807 | 0.00% | 2026-07-07 |
| Robert B Bazemore Director · +455,237 options |
Insider | 44,642 | 0.00% | 2025-03-20 |
| James R Neal Director · +238,123 options |
Insider | 36,271 | 0.00% | 2025-03-20 |
Share count 155,758,529,533 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for AKTX and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →